In July 2017, H.U. Group Research Institute was founded with the aim of consolidating the fundamental research operations within H.U. Group in order to create products and services from novel ideas that will serve as medium- and long-term drivers of growth.
We actively promote open innovation in collaboration with external research organizations, corporate ventures, as well as other industries, primarily in ①innovation in analytics platforms, ②core technologies in medical innovation, and ③utilization of medical information.
In addition, organic collaboration among various businesses within H.U. Group centered around our research institute will allow for efficient development and assessment, which will expedite development that leverages group synergy. In the long run, we endeavor to not only create new business, but new industries through revolutionizing and integrating our technologies and business models.
We aim to become leaders in the life sciences and medical innovation through science.
The two pillars of H.U. Group Research Institute are research and development, and the commercialization of results.
Research & Development in the Life Sciences
We promote innovation in the field of the life sciences with an emphasis on information, technology, and service.
Commercialization of Research Results
We will create new businesses that can serve as future drivers of growth in the life sciences fields.
We are currently engaged in research and development that harnesses cutting-edge microbiome analysis technology for the diagnosis and treatment of diseases.